Table 1. Glioma patient sample information.
Samples were grouped into sequencing pools based on available clinical information. The total number of sequencing reads for each pool is also shown.
| Sample Number | Grade | Survival (mo) | Sequencing Pool | Average Survival | Whole Transcriptome Reads | Small RNA reads |
|---|---|---|---|---|---|---|
| 1 | GBM | 6 | A | < 6 month | 75321717 | 20724499 |
| 2 | 3 | |||||
| 3 | 4 | |||||
| 4 | 1 | |||||
| 5 | 6 | |||||
|
| ||||||
| 6 | GBM | 11 | B | 10–15 months | 75295418 | 21275202 |
| 7 | 10 | |||||
| 8 | 11 | |||||
| 9 | 13 | |||||
| 10 | 15 | |||||
|
| ||||||
| 11 | GBM | 15 | C | Intermediate > 1 year | 52438870 | 18597970 |
| 12 | 18 | |||||
| 13 | >12 | |||||
| 14 | 20 | |||||
| 15 | >12 | |||||
|
| ||||||
| 16 | GBM | >12 | D | > 1 to 2 years | 67066205 | 22944568 |
| 17 | >24 | |||||
| 18 | >48 | |||||
| 19 | >84 | |||||
| 20 | 29 | |||||
|
| ||||||
| 21 | Oligo | 48 | E | NA | 58344119 | 19075166 |
| 22 | >48 | |||||
| 23 | >48 | |||||
| 24 | >72 | |||||
|
| ||||||
| 25 | Oligo | >72 | F | NA | 66169704 | 18095113 |
| 26 | >36 | |||||
| 27 | 36 | |||||
| 28 | >36 | |||||
|
| ||||||
| 29 | AO | >36 | G | NA | 87724772 | 34399996 |
| 30 | 2 | |||||
| 31 | 24 | |||||
| 32 | >60 | |||||
| 33 | 24 | |||||
| 34 | 60 | |||||
| 35 | NA | |||||
|
| ||||||
| 36 | AA | >36 | H | NA | 70196537 | 36178145 |
| 37 | 35 | |||||
| 38 | NA | |||||
| 39 | >36 | |||||
| 40 | >36 | |||||
|
| ||||||
| 41 | Adult Normal | NA | I | NA | 57701862 | 42319647 |
Abbreviations: GBM, glioblastoma; Oligo, oligodendroglioma; AO, anaplastic oligodendroglioma; AA, anaplastic astrocytoma; NA, no survival data available or not applicable.